by Brandon Tudor | Feb 23, 2026 | Blog
Here are the top 10 liver-related events (LREs) commonly used in clinical research and outcome studies of chronic liver disease. “LREs” refer to major clinical complications and outcomes that indicate progression of liver disease and substantially impact prognosis,...
by Brandon Tudor | Feb 19, 2026 | Blog
Comparison between traditional hepatobiliary surgery for HCC and HistoSonics’ Edison (histotripsy). 1) What “traditional hepatobiliary surgery for HCC” usually means A. Curative-intent surgery Partial hepatectomy (liver resection): Remove the tumor-bearing portion of...
by Brandon Tudor | Feb 15, 2026 | Blog
Ways to frame liver disease symptoms There are two key categories: 1) Usually no symptoms earlyFatty liver disease often has no noticeable symptoms until it progresses. Most people are diagnosed via routine blood tests or imaging, not symptoms. 2) Possible...
by Brandon Tudor | Feb 11, 2026 | Blog
Here’s a summary of the Gastroenterology Advisor article “Cannabis Use Linked to Better Hepatic Outcomes, Worse Cardiovascular Outcomes in MASLD” — Key Findings from the Study Population studied: >3.3 million adults hospitalized with MASLD between...
by Brandon Tudor | Feb 3, 2026 | Blog
The HEP Mag article “Closing equity gaps in cirrhosis & liver cancer care” is eye-opening. Summary: Closing Equity Gaps in Cirrhosis and Liver Cancer Care Two new studies from UT Southwestern highlight how trust, communication, health literacy, and access to...
